Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Other Non-Current Assets (2010 - 2023)

Talphera (TLPH) posted Other Non-Current Assets of $20000.0 for Q4 2023, little changed on a QoQ basis from $20000.0 in Q3 2023, and down 99.86% year-over-year from $13.9 million in Q4 2022.

Analysis

Talphera (TLPH) Other Non-Current Assets (2010 - 2023) Analysis & Trends

Talphera has reported Other Non-Current Assets for 14 years, with the latest figure at $20000.0 in Q4 2023.

  • On a quarterly basis, Other Non-Current Assets fell 99.86% year-over-year to $20000.0 in Q4 2023; TTM through Dec 2023 was $20000.0, a 99.86% decrease from a year earlier, with the FY2023 full-year figure at $20000.0, down 99.86% from the prior year.
  • Other Non-Current Assets was $20000.0 for Q4 2023 at Talphera, roughly flat from $20000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $13.9 million in Q4 2022, with the low at $20000.0 in Q3 2023.
  • Average Other Non-Current Assets over 5 years is $2.2 million, with a median of $901000.0 recorded in 2019.
  • The largest YoY upside for Other Non-Current Assets was 1231.8% in 2023 against a maximum downside of 99.86% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $1.2 million in 2019, then surged by 320.88% to $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then jumped by 178.72% to $13.9 million in 2022, then tumbled by 99.86% to $20000.0 in 2023.
  • The last three Other Non-Current Assets figures came in at $20000.0 (Q4 2023), $20000.0 (Q3 2023), and $70000.0 (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Talphera 92.90 Mn 92.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 20,000.00
Sep 30, 2023 20,000.00
Jun 30, 2023 70,000.00
Mar 31, 2023 3.48 Mn
Dec 31, 2022 13.94 Mn
Sep 30, 2022 251,000.00
Jun 30, 2022 257,000.00
Mar 31, 2022 261,000.00
Dec 31, 2021 5.00 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 5.00 Mn
Mar 31, 2021 70,000.00
Dec 31, 2020 5.00 Mn
Sep 30, 2020 720,000.00
Jun 30, 2020 784,000.00
Mar 31, 2020 902,000.00
Dec 31, 2019 1.19 Mn
Sep 30, 2019 984,000.00
Jun 30, 2019 1.02 Mn
Mar 31, 2019 900,000.00